Literature DB >> 23473411

Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009.

Alan Rozanski1, Heidi Gransar, Sean W Hayes, James Min, John D Friedman, Louise E J Thomson, Daniel S Berman.   

Abstract

OBJECTIVES: This study sought to assess whether the frequency of inducible myocardial ischemia during stress-rest single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) has changed over time.
BACKGROUND: The prevalence of cardiac death and other clinical cardiac events have declined in recent decades, but heretofore no study has examined if there has been a temporal change in the frequency of inducible myocardial ischemia during cardiac stress testing.
METHODS: We assessed 39,515 diagnostic patients undergoing stress-rest MPI between 1991 and 2009. Patients were assessed for change in demographics, clinical symptoms, risk factors, and frequency of abnormal and ischemic SPECT-MPI.
RESULTS: There was a marked progressive decline in the prevalence of abnormal SPECT studies, from 40.9% in 1991 to 8.7% in 2009 (p < 0.001). Similarly, the prevalence of ischemic SPECT-MPI declined, from 29.6% to 5.0% (p < 0.001), as did the prevalence of severe ischemia. The decline of SPECT-MPI abnormality occurred among all age and symptom subgroups, falling to only 2.9% among recent exercising patients without typical angina. We also noted a progressive trend toward performing more pharmacological rather than exercise stress in all age and weight groups, and pharmacological stress was more likely than exercise to be associated with SPECT-MPI abnormality (odds ratio: 1.43, 95% confidence interval: 1.3 to 1.5; p < 0.001).
CONCLUSIONS: Over the past 2 decades, the frequency and severity of abnormal stress SPECT-MPI studies has progressively decreased. Notably, the frequency of abnormal SPECT-MPI is now very low among exercising patients without typical angina. These findings suggest the need for developing more cost-effective strategies for the initial work-up of patients who are presently at low risk for manifesting inducible myocardial ischemia during cardiac imaging procedures.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23473411     DOI: 10.1016/j.jacc.2012.11.056

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  128 in total

1.  Pessimistic prophets.

Authors:  H William Strauss; Jagat Narula
Journal:  J Nucl Cardiol       Date:  2015-11-05       Impact factor: 5.952

2.  Prognostic value of transient ischemic dilation with regadenoson myocardial perfusion imaging.

Authors:  Davis Lester; Stephanie El-Hajj; Ayman A Farag; Pradeep Bhambhvani; Lindsey Tauxe; Jaekyeong Heo; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-10-21       Impact factor: 5.952

3.  Implementation of stress-only imaging: What will it take?

Authors:  John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2015-12-15       Impact factor: 5.952

4.  Vasodilator stress agents for myocardial perfusion imaging.

Authors:  Rayan Saab; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2016-02-02       Impact factor: 5.952

5.  Use of coronary artery calcium scanning as a triage for cardiac ischemia testing.

Authors:  Alan Rozanski; Seth Uretsky; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2016-02-03       Impact factor: 5.952

6.  Choosing exercise or pharmacologic stress imaging, or exercise ECG testing alone: How to decide.

Authors:  Jorge A Gonzalez; George A Beller
Journal:  J Nucl Cardiol       Date:  2016-02-03       Impact factor: 5.952

Review 7.  New insights from major prospective cohort studies with cardiac CT.

Authors:  Sumbal A Janjua; Udo Hoffmann
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

8.  Hybrid myocardial imaging for risk stratification prior to kidney transplantation: added value of coronary calcium and epicardial adipose tissue.

Authors:  Cristina Karohl; Luis D'Marco; Antonio Bellasi; Paolo Raggi
Journal:  J Nucl Cardiol       Date:  2013-09-12       Impact factor: 5.952

Review 9.  Assessing clinical impact of myocardial perfusion studies: ischemia or other prognostic indicators?

Authors:  Todd D Miller; John Wells Askew; Joerg Herrmann
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

10.  Prediction of cardiac death after adenosine myocardial perfusion SPECT based on machine learning.

Authors:  David Haro Alonso; Miles N Wernick; Yongyi Yang; Guido Germano; Daniel S Berman; Piotr Slomka
Journal:  J Nucl Cardiol       Date:  2018-03-14       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.